Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VALN · against 474 other Healthcare companies of similar size
Ranked #429 of 475 · scores higher than 10% of peers · safety percentile 10
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)47 peers with a safety percentile of 0–9, including VALN · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VALN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 442 reported | 2.59× | 0.19× | 4% | 33% | |
| BetaLower is better · 455 reported | 1.37 | 0.40 | 9% | 33% | |
| Current ratioHigher is better · 470 reported | 2.16× | 2.84× | 40% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.0B USD | 99 | 35 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 425 | 427M USD | 11 | 7 | |
| 426 | 487M USD | 11 | 24 | |
| 427 | 838M USD | 11 | 33 | |
| 428 | 365M EUR (≈$401M) | 10 | 44 | |
| 429 | 522M USD | 10 | 12 | |
| 430 | 1.2B SGD (≈$945M) | 10 | 35 | |
| 431 | 320M USD | 10 | 44 | |
| 432 | 336M USD | 9 | 43 | |
| 433 | 464M USD | 9 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score